tm logo
SELECTRAP
Live/Pending
SUSPENSION LETTER - MAILED

mailed

on 05 Jul 2024

Last Applicant/ Owned by

Serial Number

79367019 filed on 13th Mar 2023

Registration Number

N/A

Correspondent Address

Max Vern

Max Vern AMSTER, ROTHSTEIN & EBENSTEIN LLP

New York, NY 10174

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

SELECTRAP

Immunostimulants; pharmaceutical preparations for treating malignant tumors; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes, namely, the treatment of cancer and biological preparations containing recombinant protein for use in hum Read More

Classification Information


Class [005]
Pharmaceutical Products


Immunostimulants; pharmaceutical preparations for treating malignant tumors; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for medical or veterinary purposes, namely, the treatment of cancer and biological preparations containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; polyclonal antibodies for medical purposes; pharmaceuticals, namely, pharmaceutical preparations for the treatment of cancer and pharmaceuticals containing recombinant protein for use in human and veterinary medicine, namely, the treatment of cancer, autoimmune diseases, inflammatory diseases, metabolic diseases and viral diseases; pharmaceutical preparations for the treatment of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for use in oncology; tumor suppressing agents; monoclonal antibodies for medical purposes; bispecific antibodies for the treatment of medical conditions; bispecific antibodies for medical purposes; antibody pharmaceuticals for treating cancer; antibody diagnostic reagents for medicinal use; antibody diagnostic reagents for medical purposes; antibody reagents for medical purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79367019

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 28193/101

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
20th Sep 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04th Sep 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04th Sep 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05th Jul 2024LETTER OF SUSPENSION E-MAILED
05th Jul 2024SUSPENSION LETTER WRITTEN
05th Jul 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
07th Jun 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
07th Jun 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
07th Jun 2024TEAS/EMAIL CORRESPONDENCE ENTERED
08th Jan 2024REFUSAL PROCESSED BY IB